In ovarian cancer stem cells, trimebutine maleate dramatically suppressed tumor growth in vivo and in vitro through the Wnt/β-catenin, Notch, and Hedgehog pathways by blocking both BK channels and voltage-gated calcium channels [123]. The gene discussed is KCNMA1; the disease is ovarian carcinoma.